BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 902593)

  • 21. [Complement 3 in various chronic kidney diseases].
    Dimitrova S; Belovezhdov N
    Ter Arkh; 1977; 49(6):110-3. PubMed ID: 898032
    [No Abstract]   [Full Text] [Related]  

  • 22. [Glomerular localization of the early components of complement in glomerulonephritis].
    Barbiano di Belgiojoso G; Tarantino A; Durante A; Guerra L
    Minerva Nefrol; 1974; 21(3):169-78. PubMed ID: 4463297
    [No Abstract]   [Full Text] [Related]  

  • 23. Mesangiocapillary glomerulonephritis and persistent hypocomplementemia.
    Cameron JS; Ogg CS; Turner DR; Weller RO; White RH; Glasgow EF; Peters DK; Martin A
    Perspect Nephrol Hypertens; 1973; 1 Pt 1():541-56. PubMed ID: 4220250
    [No Abstract]   [Full Text] [Related]  

  • 24. Characterization of immunoglobulin G anti-glomerular basement membrane antibodies eluted from kidneys of patients with glomerulonephritis. II. IgG subtypes and in vitro complement fixation.
    McPhaul JJ; Dixon FJ
    J Immunol; 1971 Sep; 107(3):678-84. PubMed ID: 4999091
    [No Abstract]   [Full Text] [Related]  

  • 25. [Partial lipodystrophy, hypocomplementemia and glomerulonephritis].
    Habib R; Lévy M; Gubler MC; Broyer M; Habib M
    Arch Fr Pediatr; 1977; 34(7 Suppl):CXCVII-CCXII. PubMed ID: 931525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The complement components C8 and C9 in sera and urines of patients with chronic membranoproliferative glomerulonephritis.
    Geiger H; Day NK; Good RA
    Clin Immunol Immunopathol; 1973 Jul; 1(4):463-71. PubMed ID: 4807981
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies of complement components and renal histology in patients with dense intramembranous deposits following renal transplantation.
    Cameron JS; Bewick M; Turner D; Ogg CS; Brown CB; Williams G; Peters DK; Evans DB
    J Urol Nephrol (Paris); 1974 Dec; 80(12):982-3. PubMed ID: 4617779
    [No Abstract]   [Full Text] [Related]  

  • 28. [Letter: Membrano-proliferative, complement-deficient glomerulonephritis in myeloma. Preliminary note].
    Rifle G; Genin R; Chalopin JM
    Nouv Presse Med; 1976 Feb; 5(7):437-8. PubMed ID: 1257040
    [No Abstract]   [Full Text] [Related]  

  • 29. [Blood levels of the proactivator of the C 3 fraction of complement in glomerular nephropathies].
    Dall'Aglio P; Scarpioni L; Poisetti PG; Pantano E
    Minerva Nefrol; 1975; 22(6):262-5. PubMed ID: 1223703
    [No Abstract]   [Full Text] [Related]  

  • 30. Serum complement levels in glomerulonephritis using immunobiological methods.
    Chugh KS; Goyal S; Ganguly NK; Sharma BK; Sharma S
    Indian J Med Res; 1977 Jun; 65(6):877-85. PubMed ID: 604265
    [No Abstract]   [Full Text] [Related]  

  • 31. The natural history of membranoproliferative glomerulonephritis: its relation to the hypocomplementemia.
    West CD; Ruley EJ; Spitzer RE; Davis NC
    Perspect Nephrol Hypertens; 1973; 1 Pt 1():531-40. PubMed ID: 4620926
    [No Abstract]   [Full Text] [Related]  

  • 32. Clearances of complement components, C3 proactivator and other serum proteins in chronic membranoproliferative glomerulonephritis (CMPGN).
    Geiger H; Good RA; Day NK
    Clin Nephrol; 1975; 3(4):139-47. PubMed ID: 1149337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complement and mesangiocapillary glomerulonephritis: the role of complement deficiency in glomerulonephritis.
    Peters DK; Williams DG
    Adv Nephrol Necker Hosp; 1974; 4():67-78. PubMed ID: 4220000
    [No Abstract]   [Full Text] [Related]  

  • 34. [Studies of complement, nephritic factor, and circulating immune complexes in chronic mesangiocapillary glomerulonephritis types I and II (author's transl)].
    Mirapeix E; Yagüe J; Vives J; Revert L
    Med Clin (Barc); 1981 Jun; 77(1):21-6. PubMed ID: 7253758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal transplantation in mesangioproliferative glomerulonephritis (MPGN): relationship between the high frquency of recurrent glomerulonephritis and hypocomplementemia.
    Berthoux FC; Ducret F; Colon S; Blanc-Brunat N; Zech PY; Traeger J
    Kidney Int Suppl; 1975 Feb; (3):323-7. PubMed ID: 1099312
    [No Abstract]   [Full Text] [Related]  

  • 36. The C3 nephritic factor (C3NeF) and the heat labile complement inactivator (HLCI) in chronic hypocomplementemic mesangioproliferative glomerulonephritis.
    Berthoux FC; Carpenter CB; Traeger J; Merrill JP
    Adv Nephrol Necker Hosp; 1974; 4():91-108. PubMed ID: 4220002
    [No Abstract]   [Full Text] [Related]  

  • 37. Alterations of complement components in disease.
    Luskin AT; Tobin MC
    Am J Med Technol; 1982 Sep; 48(9):749-56. PubMed ID: 6215862
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hypothesis on the basic immune disorders, the originating cause and the development of glomerulonephritis].
    Belovezhdov N
    Vutr Boles; 1984; 23(3):39-48. PubMed ID: 6464431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunologically mediated glomerulitis of horses. II. Antiglomerular basement membrane antibody and other mechanisms in spontaneous disease.
    Banks KL; Henson JB
    Lab Invest; 1972 Jun; 26(6):708-15. PubMed ID: 4113184
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical immunology and immunopathology of glomerulonephritis (author's transl)].
    Lanzer G; Syré G
    Wien Klin Wochenschr; 1980 Sep; 92(18):631-8. PubMed ID: 6451083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.